Transaction · 0001231919-26-001102

Ra Capital Management, L.P.

RA CAPITAL MANAGEMENT, L.P., 10%, reported a transaction classified as exercise at Vor Biopharma Inc. involving 1500.000000 shares for an estimated $0.00. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code M10%
VORVor Biopharma Inc.
Trade date
Aug 24, 2026
Filing date
Aug 26, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded1.50k$0.00 per share
Holdings after0Indirect · See Footnotes
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

VOR price since this filing

Daily closing prices, with the filing date and available return windows
VOR · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d +4.6%30d -21.8%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001231919-26-001102
Stock Option (Right to Buy)
Transaction date
Aug 24, 2026
Filed Aug 26, 2026, 10:28 PM · 2d delay
Shares
1,500 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
0 sh
Indirect · See Footnotes

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction
Filing-only score

-12 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector No10% YesOther No
Footnotes & amended
  1. F1

    On September 18, 2025, the Issuer effected a 1-for-20 reverse stock split. The exercise price and number of shares underlying the stock option give effect to the reverse stock split.

  2. F2

    RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Advis…

  3. F3

    This option was granted to Joshua Resnick pursuant to the Issuer's non-employee director compensation policy. Under Mr. Resnick's arrangement with the Adviser, Mr. Resnick held the option for the bene…

  4. F4

    Held directly by the Fund.

  5. F5

    Immediately exercisable.

Original filing · 0001231919-26-001102
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

VOR